Fwd: Nonvisualization of a Sentinel Lymph Node on Lymphoscintigraphy Requiring Reinjection of Sulfur Colloid in a Patient With Breast Cancer.

---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Fri, May 23, 2008 at 7:59 PM
Subject: Nonvisualization of a Sentinel Lymph Node on Lymphoscintigraphy Requiring Reinjection of Sulfur Colloid in a Patient With Breast Cancer.
To: mesothelioma77@gmail.com


[1]Clin Nucl Med. 2008 Jun; 33(6): 389-390
Teal CB, Brem RF, Rapelyea JA, Akin EA

PURPOSE:: The injection techniques and use of lymphoscintigraphy for sentinel lymph node (SLN) biopsy in breast cancer patients vary. Some do not advocate routine use of lymphoscintigraphy. The purpose of this case report is to illustrate when lymphoscintigraphy should be used. METHODS:: At our institution, we use periareolar intradermal injections of 0.6 mCi Tc-99m sulfur colloid followed by lymphoscintigraphy with reported identification rates greater than 99%. The only patient in our series who did not have a SLN identified had presented after excisional biopsy of an upper outer quadrant cancer. We report the case of another patient who presented after excision of an upper outer quadrant invasive ductal carcinoma and had no evidence of lymphatic drainage on lymphoscintigraphy after the periareolar injections of radioisotope. RESULTS:: Additional injections of 0.4 mCi Tc-99m sulfur colloid were performed lateral to the incision in the upper outer quadrant. On lymphoscintigraphy a SLN was visualized and was subsequently successfully identified intraoperatively. CONCLUSION:: This case report supports the value of lymphoscintigraphy for successful identification of a SLN in a patient with prior surgery. We therefore recommend imaging patients who have had prior breast surgery, particularly excisions in the upper outer quadrant.



___
Source: http://www.hubmed.org/display.cgi?uids=18496442
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Simultaneous thigh muscle metastasis from lung cancer and Escherichia coli gas producing myonecrosis.

---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Fri, May 23, 2008 at 7:59 PM
Subject: Simultaneous thigh muscle metastasis from lung cancer and Escherichia coli gas producing myonecrosis.
To: mesothelioma77@gmail.com


[1]Skeletal Radiol. 2008 May 22;
Martinez GE, Coursey CA, Dodd L, Martinez S

We present the case of a 41-year-old man with known large cell lung cancer who had undergone left pneumonectomy 7 months prior and who presented with a large intramuscular mass involving the posterior left thigh and upper calf. This thigh mass was ultimately surgically explored, and specimens yielded both Escherichia coli organisms and cells reflecting a skeletal muscle metastasis from the patient's known lung cancer. The patient was also found to have a rectal metastasis from his lung cancer. Intramuscular abscesses produced by gastrointestinal tract flora are a well-known presentation of colon cancer. To our knowledge, this is the first case report of the simultaneous occurrence of a skeletal muscle metastasis and an E. coli abscess in the same anatomic location. We believe the patient's rectal metastasis may have been the intermediate step in this process.



___
Source: http://www.hubmed.org/display.cgi?uids=18496688
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Mammographic density using two computer-based methods in an isoflavone trial.

---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Fri, May 23, 2008 at 7:59 PM
Subject: Mammographic density using two computer-based methods in an isoflavone trial.
To: mesothelioma77@gmail.com


[1]Maturitas. 2008 May 19;
Kataoka M, Atkinson C, Warren R, Sala E, Day NE, Highnam R, Warsi I, Bingham SA

OBJECTIVES: Mammographic density is a useful biomarker of breast cancer risk. Computer-based methods can provide continuous data suitable for analysis. This study aimed to compare a semi-automated computer-assisted method (Cumulus) and a fully automated volumetric computer method (standard mammogram form (SMF)) for assessing mammographic density using data from a previously conducted randomised placebo-controlled trial of an isoflavone supplement. METHODS: Mammograms were obtained from participants in the intervention study. A total of 177 women completed the study. Baseline and follow-up mammograms were digitised and density was estimated using Cumulus (read by two readers) and SMF. Left-right correlation, changes in density over time, and difference between intervention and control groups were evaluated. Changes of density over time, and changes between intervention group and control group were examined using paired t-test and Student's t-test, respectively. RESULTS: Inter-reader correlation coefficient by Cumulus was 0.90 for dense area, and 0.86 for percentage density. Left-right correlation of percent density was lower in SMF than in Cumulus. Among all women, percentage density by Cumulus decreased significantly over time, but no change was seen for SMF percentage density. The intervention group showed marginally significant greater reduction of percent density by Cumulus compared to controls (p=0.04), but the difference became weak after adjustment for baseline percent density (p=0.06). No other measurement demonstrated significant difference between intervention and control groups. CONCLUSIONS: This comparison suggests that slightly different conclusions could be drawn from different methods used to assess breast density. The development of a more robust fully automated method is awaited.



___
Source: http://www.hubmed.org/display.cgi?uids=18495387
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: LA jury awards $9.7 million in asbestos suit (The Fresno Bee)

---------- Forwarded message ----------
From: Yahoo! News Search Results for asbestos cancer <rssfwd@rssfwd.com>
Date: Fri, May 23, 2008 at 7:59 PM
Subject: LA jury awards $9.7 million in asbestos suit (The Fresno Bee)
To: mesothelioma77@gmail.com


A jury awarded $9.7 million to a Georgia man who said he developed chest cancer decades after he was exposed to asbestos while serving as a Navy machinist's mate aboard the USS Preble in Long Beach.

Fri, 23 May 2008 18:06:27 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/asbestos+cancer/SIG=11i2bk2ef/*http%3A//www.fresnobee.com/384/story/622490.html
--
 Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc